How tumours prevent formation of immune responses
Scientists found that preventing the effects of prostaglandin E2 could be an effective therapy to overcome tumour defence.
List view / Grid view
Scientists found that preventing the effects of prostaglandin E2 could be an effective therapy to overcome tumour defence.
The mini-colons are topobiologically complex, can be induced to develop tumours in targeted areas and reduce the use of animal models.
Four previously unknown genetic variants provide a new understanding of differences in risk between individuals of varying ancestries.
A new method for a fragmentation-based identification of lipids could enable the study of cancer cells in detail not seen before.
The pharmacological inhibition of class IIa HDACs could be a therapeutic approach for addressing Th17-related inflammatory and autoimmune diseases.
In mouse models, the differences between oocytes collected by natural or stimulated approaches were investigated.
It was discovered that targeting RAS proteins prevent cancer cells from using different signalling pathways to escape cell death.
Researchers find the mechanism which may underly the onset and progression of age-related neurodegenerative diseases.
The new study found T3s treatment exhibited neuroprotective effects in HFSD-fed mice by mitigating oxidative stress.
The move to Cambridge Innovation Park reflects the continued growth of Zyme's internal team and client network.
The new films killed over 80 percent of cancer cells, reduced recurrence rates and minimised undesirable chemotherapy side effects.
Researchers have developed a new tool called ‘Uveal Melanoma Immunogenic Score’ to predict which patients will respond to adoptive therapy.
A urine-based test that detects ctDNA from HPV-positive head and neck cancers could facilitate its early detection.
Researchers have identified that gestational diabetes is associated with a deficit in placental expression of IGFBP1.
The new findings could result in a clinical trial to assess whether a one-year course of treatment could stop brain tumours.